Is Banco Macro BMA stock fading in strength Q4 2025 Profit Exceeds Views AbbVie Inc ABBV Submits SKYRIZI Subcutaneous Crohns Regimen to FDA But NearTerm Upside Remains Capped By Competitive Risks ConocoPhillips COP Sector Consolidation Catalyst as Shells 136B ARC Resources Acquisition Signals Upstream Value Upside